ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko03040	Spliceosome	37/173	145/7206	1.18591042728e-28
ko03030	DNA replication	21/173	38/7206	5.74263092656e-25
ko03460	Fanconi anemia pathway	17/173	51/7206	9.65354886517e-16
ko03410	Base excision repair	14/173	38/7206	7.30776873253e-14
ko03440	Homologous recombination	14/173	41/7206	2.50166126827e-13
ko04110	Cell cycle	23/173	145/7206	3.31151728114e-13
ko04111	Cell cycle - yeast	17/173	90/7206	2.71592584106e-11
ko03420	Nucleotide excision repair	12/173	46/7206	4.79244670281e-10
ko00240	Pyrimidine metabolism	16/173	110/7206	5.97449330217e-09
ko03430	Mismatch repair	8/173	22/7206	2.25402157079e-08
ko04113	Meiosis - yeast	11/173	70/7206	7.0393110807e-07
ko05168	Herpes simplex infection	14/173	182/7206	0.000112175331534
ko00230	Purine metabolism	13/173	194/7206	0.00075285121137
ko03015	mRNA surveillance pathway	8/173	93/7206	0.00168457883779
ko03013	RNA transport	11/173	166/7206	0.00209211077742
ko04218	Cellular senescence	11/173	177/7206	0.00345042416372
ko05222	Small cell lung cancer	7/173	89/7206	0.00536916348822
ko04010	MAPK signaling pathway	1/173	321/7206	0.00748832455987
ko04115	p53 signaling pathway	6/173	74/7206	0.00844474609665
ko04024	cAMP signaling pathway	1/173	279/7206	0.015127353697
ko03022	Basal transcription factors	4/173	44/7206	0.0206473914198
ko04810	Regulation of actin cytoskeleton	1/173	264/7206	0.0220151908721
ko05205	Proteoglycans in cancer	1/173	271/7206	0.0228552768266
ko05166	HTLV-I infection	13/173	292/7206	0.0291638655418
ko04510	Focal adhesion	1/173	240/7206	0.0314634973982
ko05203	Viral carcinogenesis	12/173	277/7206	0.0426379085545
ko04120	Ubiquitin mediated proteolysis	7/173	138/7206	0.0479542508615
ko03450	Non-homologous end-joining	2/173	15/7206	0.0490265431436